Sargassum fusiforme (Hijiki)

Hijiki (Sargassum fusiforme) is a brown seaweed containing bioactive compounds like SP-4 polysaccharides and 24S-saringosterol. These compounds may provide antiviral effects through HIV-1 fusion inhibition and cholesterol management via LXR-mediated pathways.

Origin & History

Sargassum fusiforme (Hijiki) is a brown seaweed native to coastal regions of East Asia, particularly Korea, Japan, and China, where it grows on rocky seabeds in intertidal zones. It is harvested from wild or cultivated sources and typically processed by drying the whole plant or extracting polysaccharides, minerals, and lipids through methods like methanol extraction or sulfation modification.

Historical & Cultural Context

In traditional East Asian medicine (Korean, Japanese, Chinese systems), Hijiki has been used for centuries as a nutrient-dense food for mineral supplementation (calcium, iodine, magnesium) and general health promotion. Specific historical durations or traditional indications are not detailed in available sources.

Health Benefits

• Potential anti-viral activity: In vitro studies showed SP-4 fraction inhibited HIV-1 fusion and reverse transcriptase (preliminary evidence only)
• Cholesterol management: Contains selective LXR agonist sterols like 24S-saringosterol that may lower cholesterol via LXR-mediated transactivation (animal/in vitro evidence)
• Anti-inflammatory effects: Rich in phlorotannins (fuhalol-type) showing anti-inflammatory properties in preclinical models (no human trials)
• Mineral supplementation: High in calcium (0.87-1.17%), iron (14.3-47.6 mg/100g DW), and zinc (1.5-1.6 mg/100g DW) (compositional data only)
• Potential anti-obesity effects: Noted in pharmacological reviews but limited to animal/in vitro models without human trial specifics

How It Works

SP-4 polysaccharide fractions from hijiki inhibit HIV-1 fusion and reverse transcriptase activity in laboratory studies. The sterol compound 24S-saringosterol acts as a selective liver X receptor (LXR) agonist, promoting LXR-mediated transactivation pathways involved in cholesterol homeostasis and lipid metabolism.

Scientific Research

No human clinical trials, RCTs, or meta-analyses on Sargassum fusiforme were identified in the research. Evidence is limited to in vitro and animal studies, with one in vitro study isolating fraction SP-4 that showed HIV-1 inhibition activity (no PMID available).

Clinical Summary

Current evidence for hijiki is limited to preliminary in vitro studies examining specific bioactive fractions. Laboratory research demonstrated SP-4 polysaccharides' antiviral properties against HIV-1, while sterol analysis identified LXR agonist activity of 24S-saringosterol. No human clinical trials have been conducted to establish therapeutic efficacy, safety profiles, or optimal dosing protocols for hijiki supplementation.

Nutritional Profile

Per 100 g dry weight (approximate values, varying by harvest location and season): Protein: 7–12 g (contains all essential amino acids, though limiting in methionine and cysteine; digestibility moderate due to cell-wall polysaccharides). Total dietary fiber: 32–60 g (predominantly soluble: alginates 15–30 g, fucoidans 5–15 g; insoluble: cellulose 3–8 g). Fat: 1–5 g (rich in polyunsaturated fatty acids; EPA [eicosapentaenoic acid, C20:5 n-3] ~0.1–0.5 g; arachidonic acid [C20:4 n-6] present in smaller amounts; also contains fucosterol ~50–200 mg and 24S-saringosterol, a selective LXRβ agonist sterol at trace-to-low mg levels). Carbohydrates (non-fiber): 20–40 g (including mannitol ~5–10 g as a sugar alcohol). Minerals (notably high): Calcium 600–1400 mg; Iron 30–60 mg (primarily non-heme, bioavailability enhanced by co-consumed vitamin C but reduced by alginate and phytate analogs); Magnesium 500–900 mg; Iodine highly variable, typically 20–50 mg (can exceed 100 mg in some samples — caution for thyroid-sensitive individuals; bioavailability is high as iodide); Potassium 4000–6000 mg; Sodium 1500–4000 mg; Phosphorus 40–80 mg; Zinc 1–4 mg; Manganese 1–5 mg. CAUTION: Inorganic arsenic content is notably high (typically 50–120 mg/kg dry weight), prompting food safety advisories in several countries (UK FSA, EU EFSA) recommending limited or no consumption. Vitamins: β-carotene (provitamin A) 1–5 mg; Vitamin K1 ~60–80 µg; Vitamin B2 (riboflavin) 0.3–0.6 mg; Folate 100–200 µg; Vitamin C 5–15 mg (degrades significantly upon drying); Vitamin E (α-tocopherol) 1–3 mg; Niacin 1–3 mg. Bioactive compounds: Fucoidans (sulfated polysaccharides, 5–15 g/100 g dry wt, MW range 20–200 kDa; exhibit immunomodulatory, anticoagulant, and potential anti-viral properties; oral bioavailability is low due to high molecular weight but partial absorption of lower-MW fragments occurs); Phlorotannins (fuhalol-type and phlorethol-type polyphenols, ~0.5–3 g/100 g dry wt; demonstrate antioxidant, anti-inflammatory, and α-glucosidase inhibitory activity; bioavailability is limited, with most activity likely exerted locally in the GI tract); Fucoxanthin (carotenoid, ~0.01–0.1 mg/100 g dry wt in hijiki — much lower than in Undaria or Laminaria species; lipid-soluble, bioavailability improved with dietary fat co-ingestion, metabolized to fucoxanthinol and amarouciaxanthin A); Laminaran (β-1,3-glucan, 1–5 g/100 g dry wt; potential prebiotic and immunostimulatory effects); Sulfated polysaccharide fraction SP-4 (characterized in HIV studies, specific to Sargassum fusiforme, inhibited HIV-1 fusion and reverse transcriptase in vitro at µg/mL concentrations — oral bioavailability and in vivo relevance unknown). Bioavailability notes overall: Mineral bioavailability is modulated by the high alginate and fucoidan content, which can chelate divalent cations (Ca²⁺, Fe²⁺, Zn²⁺), potentially reducing absorption by 20–50%. Iodine is readily bioavailable. The high inorganic arsenic content is also highly bioavailable, making risk-benefit assessment critical. Soaking and boiling hijiki before consumption can reduce both arsenic and excess iodine by 30–70%, though it also leaches water-soluble vitamins and minerals.

Preparation & Dosage

No clinically studied dosage ranges for human use are reported. Studies mention extracts with varying fucosterol content (0.249-1.067 mg/g) but without established dosing protocols. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Kelp, Wakame, Kombu, Dulse, Spirulina

Safety & Interactions

Hijiki consumption has been associated with elevated arsenic levels, as this seaweed can bioaccumulate inorganic arsenic from seawater. Several countries including the UK and Canada have issued advisories limiting hijiki consumption due to arsenic contamination concerns. Pregnant and breastfeeding women should avoid hijiki due to potential arsenic toxicity risks. No specific drug interactions have been documented, though the iodine content may affect thyroid medications.